{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-025951","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2024-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.656228+00:00","generated_at":"2026-06-06T07:13:48.130068+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Disc Medicine appoints Jean Franchi as CFO effective Feb 7, 2024; promotes Jonathan Yu to COO","bullets":["Jean Franchi appointed CFO, replacing Joanne Bryce who transitions to consulting; effective Feb 7, 2024.","Franchi receives $515k base salary, $75k signing bonus, 40% target bonus; inducement equity: option for 55k shares and RSU for 36,666 shares.","Franchi brings 30+ years experience; previously CFO at Replimune, Merrimack, Dimension Therapeutics, and Genzyme.","Jonathan Yu promoted from Chief Business Officer to COO effective Feb 7, 2024.","Equity inducement awards granted outside the 2021 stock plan per Nasdaq Listing Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-025951","json":"https://secwatch.observer/filing/0001193125-24-025951.json","markdown":"https://secwatch.observer/filing/0001193125-24-025951.md","text":"https://secwatch.observer/filing/0001193125-24-025951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/d758257d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T07:13:48.130068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74b8236939","claim":"Jonathan Yu changed role as Chief Operating Officer at Disc Medicine, Inc..","evidence_excerpt":"On February 7, 2024 (the \"Promotion Date\"), the Company announced that Jonathan Yu, the Company's previous Chief Business Officer, was promoted to serve as the Company's Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"90641cfa6c","claim":"Jean M. Franchi was appointed as Chief Financial Officer and Treasurer at Disc Medicine, Inc..","evidence_excerpt":"On February 7, 2024, the Company announced the appointment of Jean M. Franchi as Chief Financial Officer and Treasurer, effective February 7, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"db9cce5af1","claim":"Joanne Bryce departed as Chief Financial Officer and Treasurer at Disc Medicine, Inc..","evidence_excerpt":"Ms. Franchi succeeds Joanne Bryce, who, as previously announced by the Company, will depart from her role as Chief Financial Officer and Treasurer, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}